Symposium - Evidence-based Deprescribing in Denmark (2019)

Article evaluating the symposium:  Deprescribing: What is the gold standard? Themes that characterized the discussions at the first Danish symposium on evidence-based deprescribing

Download programme here

Use of evidence-based treatment guidelines support initiation and maintenance of drug treatments. However, many receive medication that is no longer needed and deprescribing of wellintentioned medication may be relevant, for instance, due to unacceptable side effects, lack of effect or the like. Deprescribing may be difficult and until recently, no evidence-based deprescribing guidelines have been available. Evidence-based deprescribing guidelines have now been developed in Canada and Australia as the first in the world.

Keynote speaker:

Dr. Barbara Farrell, BScPhm, PharmD, FCSHP, University of Ottawa, one of the initiators of the concept development concerning Evidence Based Deprescribing. Guidelines.

Focus:

• Preparation, implementation and
  evaluation of evidence-based
  deprescribing guidelines. Barbara
  Farrell, BScPhm, PharmD, FCSHP
• Use of evidence-based
  deprescribing in Denmark:
  Relevance and barriers highlighted
  from both the primary and
  secondary sectors. A general
  practitioner and a hospital doctor
  representing both sectors

Target audience:

• Health care professionals, including
  doctors and clinical Pharmacists
• Current clinical guideline developers
  and people interested in developing
  deprescribing recommendations
• Policy makers